Concepedia

GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: A randomized controlled trial

T G Stovall, Ozgul Muneyyirci‐Delale, Anthony R. Scialli

Obstetrics and Gynecology · 1995 · 96 citations · 15 references

DOI

Abstract

Both dosages of GnRH agonist plus iron were more effective than iron alone in treating the anemia of patients with uterine leiomyomas, in reducing uterine-myoma volume, and in alleviating bleeding and other leiomyoma-related symptoms.

References

15

Hysterectomy in the United States, 1988-1990

Lynne S. Wilcox, Lisa M. Koonin, R Pokras et al. · Obstetrics and Gynecology · 1994 · 680 citations

Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.

Andrew J. Friedman, D I Hoffman, Florence Comite et al. · PubMed · 1991 · 217 citations

, , +16

A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri

Andrew J. Friedman, Robert L. Barbieri, Peter M. Doubilet et al. · Fertility and Sterility · 1988 · 201 citations

, , +8

An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.

Bruce R. Carr, Paul B. Marshburn, Paul T. Weatherall et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 176 citations

, , +17

A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy

Andrew J. Friedman, Mitchell S. Rein, Debra Harrison-Atlas et al. · Fertility and Sterility · 1989 · 150 citations

, , +3